INDICATORS

More documents

Recommendations

Info

Data availability of Health services indicators 56. Vaccination coverage in children AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 58. Breast cancer screening AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 59. Cervical cancer screening AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 62. Hospital beds AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 63. Physicians employed AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 64. Nurses employed AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 65. Mobility of professionals AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 66. Medical technologies: MRI units and CT scans AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 67. Hospital in-patient discharges, limited diagnoses AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 68. Hospital daycases, limited diagnoses AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 69. Hospital daycase/in-patient discharge ratio, limited diagnoses AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 70. Average length of stay (ALOS), limited diagnoses AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 71. General practitioner (GP) utilisation AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 72. Other outpatient visits AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 73. Surgeries: PTCA, hip, cataract AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 140
74. Medicine use, selected groups AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 75. Patient mobility AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 76. Insurance coverage AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 77. Expenditures on health AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 78. Survival rates cancer AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 80. Equity of access to health care services AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 81. Waiting times for elective surgeries AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 82. Surgical wound infections AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 83. Cancer treatment delay AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 84. Diabetes control AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK Data availability of Health promotion indicators 85. Policies on environmental tobacco smoke (ETS) exposure AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 86. Policies on healthy nutrition AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 87. Policies and practices on healthy lifestyles AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 88. Integrated programmes in settings, including workplaces, schools, hospitals AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LT LU LV MT NL NO PL PT RO SE SI SK TR UK 141
Page 1:
Katri Kilpeläinen, Arpo Aromaa and
Page 4 and 5:
Publisher National Public Health In
Page 6 and 7:
ANNEXES............................
Page 8 and 9:
ECHIM undertook to assess the prese
Page 10 and 11:
ACKNOWLEDGEMENTS The project leader
Page 12 and 13:
14 University of Brighton, Faculty
Page 14 and 15:
its Work Plan 2004 (1.1. Developing
Page 16 and 17:
Public health policies aim at maint
Page 18 and 19:
Methods: • ECHIM Country Reports:
Page 20 and 21:
ECHIM was also the scientific secre
Page 22 and 23:
Jürgen Thelen, Ari-Pekka Sihvonen,
Page 24 and 25:
Typically, national health informat
Page 26 and 27:
2.3. Major international data sourc
Page 28 and 29:
discharges and beds are part of hea
Page 30 and 31:
users to assess data quality via th
Page 32 and 33:
Pieter Kramers, Rutger Nugteren, Ar
Page 34 and 35:
12/2007: WP Indicators meeting #5 1
Page 36 and 37:
The first step was to consult the W
Page 38 and 39:
3.3. Additions to the ECHI shortlis
Page 40 and 41:
It was proposed earlier that the sh
Page 42 and 43:
3. Many Public Health Programme pro
Page 44 and 45:
Documentation Sheets are divided in
Page 46 and 47:
Table 3. A Documentation Sheet for
Page 48 and 49:
Relevant dimensions (subgroups) (pr
Page 50 and 51:
Jürgen Thelen, Ari-Pekka Sihvonen,
Page 52 and 53:
for All, OECD Health Data) and topi
Page 54 and 55:
Figure 3. Availability of ECHI shor
Page 56 and 57:
Figure 5. Availability of ECHI shor
Page 58 and 59:
Antti Tuomi-Nikula, Ari-Pekka Sihvo
Page 60 and 61:
5.2. Information derived from the E
Page 62 and 63:
The Health determinants section inc
Page 64 and 65:
Excluding vital statistics, there w
Page 66 and 67:
5.4. Initial experiences at the sta
Page 68 and 69:
) Dissemination of knowledge about
Page 70 and 71:
implementation process. There was a
Page 72 and 73:
Summary of Joint Action for ECHIM G
Page 74 and 75:
indicators and the development of d
Page 76 and 77:
Nevertheless, the intention is to d
Page 78 and 79:
7.1. Current state in Europe Health
Page 80 and 81:
Arpo Aromaa & Katri Kilpeläinen 8.
Page 82 and 83:
80 ANNEXES
Page 84 and 85:
ECHI shortlist, release of June 200
Page 86 and 87:
Additions and major changes in the
Page 88 and 89:
ANNEX 2: Documentation Sheets (shor
Page 90 and 91:
6. POPULATION BY EDUCATION Definiti
Page 92 and 93: Calculation: Life expectancies are
Page 94 and 95: Calculation: 1) The European Monito
Page 96 and 97: 17. EXCESS MORTALITY BY HEATWAVES D
Page 98 and 99: Calculation: 1) Proportion of indiv
Page 100 and 101: Calculation: 1) Age-standardised in
Page 102 and 103: 27. COPD Definition: Prevalence of
Page 104 and 105: 31. INJURIES: WORKPLACE Definition:
Page 106 and 107: Calculation: 1) EHIS: Percentage of
Page 108 and 109: 38. PSYCHOLOGICAL DISTRESS Definiti
Page 110 and 111: 41. HEALTH EXPECTANCY, OTHERS Defin
Page 112 and 113: 44. REGULAR SMOKERS Definition: Per
Page 114 and 115: Calculation: 1a) For adults: Lifeti
Page 116 and 117: Notes: Exclusive versus partial bre
Page 118 and 119: Calculation: 1) Age and sex adjuste
Page 120 and 121: 58. BREAST CANCER SCREENING Definit
Page 122 and 123: 62. HOSPITAL BEDS Definition: The i
Page 124 and 125: Notes: Practising, professionally a
Page 126 and 127: Calculation: The indicator is calcu
Page 128 and 129: Calculation: Eurostat: a) Average l
Page 130 and 131: 74. MEDICINE USE, SELECTED GROUPS D
Page 132 and 133: Calculation: (1) OECD: The indicato
Page 134 and 135: 80. EQUITY OF ACCESS TO HEALTH CARE
Page 136 and 137: 84. DIABETES CONTROL Definition: Pr
Page 138 and 139: ANNEX 3: Availability of the ECHI s
Page 140 and 141: 26. Asthma AT BE BG CH CY CZ DE DK
Page 144 and 145: 142
Page 146 and 147: figure is higher than that of the C
Page 148 and 149: AUSTRIA Data availability by Countr
Page 150 and 151: BELGIUM Data availability by Countr
Page 152 and 153: BULGARIA Data availability by Count
Page 154 and 155: CROATIA Data availability by Countr
Page 156 and 157: CYPRUS Data availability by Country
Page 158 and 159: CZECH REPUBLIC Data availability by
Page 160 and 161: DENMARK Data availability by Countr
Page 162 and 163: ESTONIA Data availability by Countr
Page 164 and 165: FINLAND Data availability by Countr
Page 166 and 167: FRANCE Data availability by Country
Page 168 and 169: GERMANY Data availability by Countr
Page 170 and 171: GREECE Data availability by Country
Page 172 and 173: HUNGARY Data availability by Countr
Page 174 and 175: ICELAND Data availability by Countr
Page 176 and 177: IRELAND Data availability by Countr
Page 178 and 179: ITALY Data availability by Country
Page 180 and 181: LATVIA Data availability by Country
Page 182 and 183: LITHUANIA Data availability by Coun
Page 184 and 185: LUXEMBOURG Data availability by Cou
Page 186 and 187: MALTA Data availability by Country
Page 188 and 189: NETHERLANDS Data availability by Co
Page 190 and 191: NORWAY Data availability by Country
Page 192 and 193:
POLAND Data availability by Country
Page 194 and 195:
PORTUGAL Data availability by Count
Page 196 and 197:
SLOVENIA Data availability by Count
Page 198 and 199:
SPAIN Data availability by Country
Page 200 and 201:
SWEDEN Data availability by Country
Page 202 and 203:
TURKEY Data availability by Country
Page 204 and 205:
UNITED KINGDOM Data availability by
Page 206 and 207:
ANNEX 5: ECHIM Products website Int
Page 208 and 209:
User windows can also be found in t
Page 210 and 211:
ANNEX 6: List of abbreviations Abbr
Page 212 and 213:
Abbreviation EU-SILC E4SM Explanati
show all

INDICATORS

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?